theory clinical_91_5
imports Main

begin

typedecl entity
typedecl event

consts
  Inhibitors :: "entity ⇒ bool"
  AnticancerAgents :: "entity ⇒ bool"
  ClassOf :: "entity ⇒ entity ⇒ bool"
  Defects :: "entity ⇒ bool"
  DNARepair :: "entity ⇒ bool"
  Target :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Interfere :: "event ⇒ bool"
  With :: "event ⇒ entity ⇒ bool"
  Through :: "event ⇒ entity ⇒ bool"
  RoleOfPARP1_2 :: "entity ⇒ bool"
  DisruptingPolyADP_ribosylation :: "entity ⇒ bool"
  PARP1 :: "entity ⇒ bool"
  PARP2 :: "entity ⇒ bool"
  PolyADP_ribosylation :: "entity ⇒ bool"
  InvolvedIn :: "entity ⇒ entity ⇒ bool"
  CrucialFor :: "entity ⇒ entity ⇒ bool"
  RecoveryFromDNADamage :: "entity ⇒ bool"
  Process :: "entity ⇒ bool"
  Disrupt :: "event ⇒ bool"
  Mechanism :: "event ⇒ entity ⇒ bool"
  TargetingDefects :: "entity ⇒ bool"

(* Explanation 1: [PARP1/2] inhibitors are a class of anticancer agents that target tumor-specific defects in DNA repair by interfering with the role of PARP1/2 in recovery from DNA damage, specifically through disrupting polyADP-ribosylation *)
axiomatization where
  explanation_1: "∃x y z w e1 e2. Inhibitors x ∧ AnticancerAgents y ∧ ClassOf x y ∧ Defects z ∧ DNARepair w ∧ Target e1 ∧ Agent e1 x ∧ Patient e1 z ∧ In z w ∧ Interfere e2 ∧ Agent e2 x ∧ With e2 r ∧ RoleOfPARP1_2 r ∧ Through e2 d ∧ DisruptingPolyADP_ribosylation d"

(* Explanation 2: PARP1 and PARP2 are both involved in polyADP-ribosylation, a process crucial for recovery from DNA damage *)
axiomatization where
  explanation_2: "∀x y. (PARP1 x ∨ PARP2 x) ∧ PolyADP_ribosylation y ⟶ (InvolvedIn x y ∧ CrucialFor y z ∧ RecoveryFromDNADamage z)"

(* Explanation 3: This process is disrupted by [PARP1/2] inhibitors, which interferes with the role of PARP1/2 in recovery from DNA damage *)
axiomatization where
  explanation_3: "∃x y e1 e2. Process x ∧ Inhibitors y ∧ Disrupt e1 ∧ Agent e1 y ∧ Patient e1 x ∧ Interfere e2 ∧ Agent e2 y ∧ With e2 r ∧ RoleOfPARP1_2 r"

(* Explanation 4: Disrupting polyADP-ribosylation by [PARP1/2] inhibitors directly interferes with the role of PARP1/2 in recovery from DNA damage, which is a mechanism to target tumor-specific defects in DNA repair *)
axiomatization where
  explanation_4: "∃x y z w e1 e2. PolyADP_ribosylation x ∧ Inhibitors y ∧ Disrupt e1 ∧ Agent e1 y ∧ Patient e1 x ∧ Interfere e2 ∧ Agent e2 y ∧ With e2 r ∧ RoleOfPARP1_2 r ∧ Mechanism e2 z ∧ TargetingDefects z ∧ Defects z ∧ In z w ∧ DNARepair w"

(* Explanation 5: Interfering with the role of PARP1/2 in recovery from DNA damage is a mechanism by which [PARP1/2] inhibitors target tumor-specific defects in DNA repair *)
axiomatization where
  explanation_5: "∃x y z e1 e2. RoleOfPARP1_2 x ∧ Interfere e1 ∧ With e1 x ∧ Mechanism e1 z ∧ TargetingDefects z ∧ Inhibitors y ∧ Defects z ∧ DNARepair z ∧ Target e2 ∧ Agent e2 y ∧ Patient e2 z"

theorem hypothesis:
  assumes asm: "Inhibitors x ∧ Defects y ∧ DNARepair z"
  (* Hypothesis: [PARP1/2] inhibitors target tumour-specific defects in DNA repair through the role of PARP1/2 in recover from DNA damage *)
  shows "∃x y z e. Inhibitors x ∧ Defects y ∧ DNARepair z ∧ Target e ∧ Agent e x ∧ Patient e y ∧ In y z ∧ Through e r ∧ RoleOfPARP1_2 r"
proof -
  (* From the premise, we have known information about inhibitors, defects, and DNA repair. *)
  from asm have "Inhibitors x ∧ Defects y ∧ DNARepair z" by blast
  (* Explanation 1 provides a logical relation: Implies(A, B), Implies(A, C), and Implies(A, D). *)
  (* Explanation 4 and 5 provide the necessary link between disrupting polyADP-ribosylation and targeting defects. *)
  (* Using Implies(D, C) and Implies(C, B), we can infer that disrupting polyADP-ribosylation leads to targeting tumor-specific defects. *)
  from explanation_4 have "∃e1 e2. Disrupt e1 ∧ Agent e1 x ∧ Interfere e2 ∧ Agent e2 x ∧ With e2 r ∧ RoleOfPARP1_2 r ∧ Mechanism e2 z ∧ TargetingDefects z" sledgehammer
  (* From the above, we can infer that there exists an event e such that the inhibitors target defects through the role of PARP1/2. *)
  then have "∃e. Target e ∧ Agent e x ∧ Patient e y ∧ In y z ∧ Through e r ∧ RoleOfPARP1_2 r" <ATP>
  then show ?thesis <ATP>
qed

end
